Open AccessPlasma Levels of Long-Acting Injectable Antipsychotics in Outpatient Care: A Retrospective Analysis
Author(s) -
Martin Hýža,
Petr Šilhán,
Eva Češková,
Tomáš Skřont,
Ivana Kacířová,
R. Urinovska,
Milan Grundmann
Publication year - 2021
Publication title -
neuropsychiatric disease and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 67
eISSN - 1178-2021
pISSN - 1176-6328
DOI - 10.2147/ndt.s298050
Subject(s) - medicine , risperidone , paliperidone , retrospective cohort study , therapeutic drug monitoring , pharmacokinetics , antipsychotic , drug , clinical practice , blood sampling , schizophrenia (object oriented programming) , pharmacology , psychiatry , physical therapy
Antipsychotic efficacy in schizophrenia depends on its availability in the body. Although therapeutic outcomes remain still far from satisfactory, therapeutic drug monitoring is not a common part of clinical practice during treatment with long-acting injectable antipsychotics (LAI AP). The real effectiveness of LAI AP is thus uncertain.